Doctors Are Targeting the Wrong PSA Level, Study Finds
A Cedars-Sinai study found the effective PSA target for prostate cancer treatment is 10 times lower than what most physicians aim for.
Dr. Anand Sharma
βHealth, medicine, research, and the science of the human body.
Category Writer
Dr. Anand Sharma
Doctor and science communicator.

A Cedars-Sinai study found the effective PSA target for prostate cancer treatment is 10 times lower than what most physicians aim for.
Dr. Anand Sharma
β
Two UCLA studies found brain stem cells shift what neurons they make based on glucose metabolism and early thalamic contact.
Dr. Anand Sharma
β
The STAREE trial found atorvastatin cut major cardiovascular events 30% in healthy over-70s, but didn't extend disability-free survival.
Dr. Anand Sharma
β
AD109 cut sleep apnea breathing interruptions 44% in trials, but the FDA has questioned whether that result is clinically meaningful.
Dr. Anand Sharma
β
WashU researchers found lymph node-like structures in skull bone marrow that respond to brain cancer before distant lymph nodes even react.
Dr. Anand Sharma
β
University at Buffalo scientists built an injectable gel that lubricates joints while releasing osteoarthritis drugs for weeks at a time.
Dr. Anand Sharma
β
A magnetotactic bacterium extended C. elegans lifespan by 43.39% by suppressing ferroptosis, the iron-driven cell death linked to aging.
Dr. Anand Sharma
β
In a first trial, CD19 CAR T-cell therapy sent all six treatment-resistant rheumatoid arthritis patients into remission, three drug-free.
Dr. Anand Sharma
βA University of Oslo study found brain structure changes at least 7 years before amyloid plaques become detectable on PET scans.
Dr. Anand Sharma
βThe FDA approved Lisraya, the first oral, targeted therapy for dermatomyositis, after a Phase 3 trial showed steroid-sparing benefits.
Dr. Anand Sharma
βOxford researchers found Shingrix recipients had a 9% lower cardiovascular burden than those who got the older vaccine.
Dr. Anand Sharma
βA Cell Reports study of 28 people found cytotoxic CD4 T cells made up 17.6% of T cells in supercentenarians, versus just 4% in septuagenarians.
Dr. Anand Sharma
β